Joseph Shulman - SEC Form 4 Insider Trading Activity
Chief Technical Officer
Summary
Updated Aug 16, 2026
Joseph Shulman is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $7.11M.
Profile
Joseph Shulman serves as Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM). Shulman has reported 10 insider filings with the SEC since 2024. The most recent filing was in February 2026.
- Role
- Chief Technical Officer
Board memberships
- RHYTHM PHARMACEUTICALS, INC.
Trading Pattern
InsiderAlpha's records for Joseph Shulman go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. 22 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Joseph Shulman has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM) - 10 filings, 2024 to 2026
Recent Transactions
20Most Active Insiders Right Now
Joseph Shulman has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- VisionWave Holdings, Inc. - $7.98B of SVRE open-market activity in the last 90 days
- Magnetar Financial LLC - $6.62B of CRWV open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
- SGF FANG Holdings, LP - $2.04B of FANG open-market activity in the last 90 days
- BX Mozart ML-2 Holdco L.P. - $1.22B of MDLN open-market activity in the last 90 days
- BCP 8 Holdings Mozart Manager L.L.C. - $1.22B of MDLN open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Joseph Shulman?
Joseph Shulman serves as Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM). Shulman has reported 10 insider filings with the SEC since 2024. The most recent filing was in February 2026.…
Has Joseph Shulman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($7.11M) across all tracked filings.
Where can I see all of Joseph Shulman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Get alerts when Joseph Shulman files a new Form 4
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required